Is the new inhalable insulin for people with type1 or type 2 diabetes?
The new Afrezza insulin is for people living with Type 1 and Type 2 diabetes.
It’s a powdered insulin that penetrates the deep lung tissue. Physicians recommend that you take this rapid acting insulin before your meals. It peaks in 12-14 minutes and completely leaves your system in 2 to 3 hours.
What you need to know is that this type of insulin in not indicated for everyone. If you have chronic obstructive pulmonary disease also known as COPD, asthma or a bronchospasms this type of insulin delivery is not recommended for you.
AskNadia and receive her unique perspective on your question.
Email Nadia at AskNadia@DiabetesHealth.com.
Nadia’s feedback on your question is in no way intended to initiate or replace your healthcare professionals therapy and advice. Please check in with your medical team to discuss your diabetes management concerns.
View Nadia’s Videos
Nadia was not only born into a family with diabetes but also married into one. She was propelled at a young age into “caretaker mode,” and with her knowledge of the scarcity of resources, support, and understanding for people with diabetes, co-founded Diabetes Interview now Diabetes Health magazine.
Nadia holds 11 nominations for her work as a diabetes advocate. Her passion for working in the diabetes community stemmed from her personal loss. She has used her experience as a caretaker to forge a career in helping others.
She has been featured on ABC, NBC, CBS, and other major cable networks. Her publications, medical supply business and website have been sited, recognized and published in Herb Caen, WSJ, Ann Landers, Lee Iacocca, Entrepreneur magazine, Houston News, Phili.com, Brand Week, Drug Topics and many other media outlets.